-
Cholangiocarcinoma, also
known as bile duct cancer, is a type of
cancer that
forms in the bile ducts.
Symptoms of
cholangiocarcinoma may
include abdominal...
-
common types are HCC,
which makes up 80% of
cases and
intrahepatic cholangiocarcinoma. The
diagnosis may be
supported by
blood tests and
medical imaging...
- play
crucial roles in the
pathogenesis and
progression of
cholangiocarcinoma.
Cholangiocarcinoma is
considered to be an
incurable and
rapidly lethal cancer...
-
including liver cancer,
gallbladder carcinoma,
colorectal cancer, and
cholangiocarcinoma. The
underlying cause of PSC is unknown.
Genetic susceptibility, immune...
- A
Klatskin tumor (or
hilar cholangiocarcinoma) is a
cholangiocarcinoma (cancer of the
biliary tree)
occurring at the
confluence of the
right and left...
-
viverrini and
Opisthorchis felineus).
Chronic infection may lead to
cholangiocarcinoma, a
cancer of the bile ducts.
Medical care and loss of
wages caused...
-
recurrent pyogenic cholangitis and
cancer (
cholangiocarcinoma).
Opisthorchiasis is the
leading cause of
cholangiocarcinoma in
Thailand and Laos.
Clonorchis sinensis...
- both
found in
eastern and
southeastern Asia, and are
responsible for
cholangiocarcinoma (cancer of the bile ducts). The
International Agency for Research...
-
medication for the
treatment of
acute myeloid leukemia (AML) and
cholangiocarcinoma. It is a
small molecule inhibitor of
isocitrate dehydrogenase-1 (IDH1)...
- name Lytgobi, is an anti-cancer
medication used for the
treatment of
cholangiocarcinoma (bile duct cancer). It is a
kinase inhibitor. It is
taken by mouth...
